Heterogeneity of in vitro-cultured CD34+ cells isolated from peripheral blood

Cytotherapy

Volumn 17, Issue 10, 2015, Pages 1472-1484

  Jobin, Christine ^a,b   Cloutier, Marc ^b   Simard, Carl ^b   Néron, Sonia ^a,b  

^a UNIVERSITÉ LAVAL   (Canada)

^b HÉMA QUÉBEC   (Canada)

Author keywords

Flow cytometry; Heterogeneity; Peripheral blood; Phenotype; Progenitor cells; Stem cells

Indexed keywords

CD135 ANTIGEN; CYTOKINE; INTERLEUKIN 3; STEM CELL FACTOR; THROMBOPOIETIN; CD34 ANTIGEN; IL3 PROTEIN, HUMAN; IL6 PROTEIN, HUMAN; INTERLEUKIN 6;

ARTICLE; CD34+ STEM CELL; CELL COUNT; CELL DIFFERENTIATION; CELL EXPANSION; CELL HETEROGENEITY; CELL ISOLATION; CELL VIABILITY; CLUSTER ANALYSIS; COMPUTER PROGRAM; CONTROLLED STUDY; ERYTHROCYTE PROGENITOR CELL; FLOW CYTOMETRY; HUMAN; HUMAN CELL; IN VITRO STUDY; MEGAKARYOCYTE; PHENOTYPE; PRIORITY JOURNAL; PURIFICATION; STEM CELL; STEM CELL CULTURE; ADULT; BONE MARROW; BONE MARROW CELL; CELL CULTURE; CELL HYPOXIA; CYTOLOGY; ERYTHROCYTE; FETUS BLOOD; HEMATOPOIETIC STEM CELL; HEMATOPOIETIC STEM CELL TRANSPLANTATION; IMMUNOLOGY; MONONUCLEAR CELL;

ADULT; ANTIGENS, CD34; BONE MARROW; BONE MARROW CELLS; CELL DIFFERENTIATION; CELL HYPOXIA; CELLS, CULTURED; ERYTHROCYTES; FETAL BLOOD; FLOW CYTOMETRY; FMS-LIKE TYROSINE KINASE 3; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HEMATOPOIETIC STEM CELLS; HUMANS; INTERLEUKIN-3; INTERLEUKIN-6; LEUKOCYTES, MONONUCLEAR; MEGAKARYOCYTES; STEM CELL FACTOR; THROMBOPOIETIN;

EID: 84940888900     PISSN: 14653249     EISSN: 14772566     Source Type: Journal    
DOI: 10.1016/j.jcyt.2015.05.006     Document Type: Article

References (64)

1. Passweg J.R., Baldomero H., Gratwohl A., Bregni M., Cesaro S., Dreger P., et al. The EBMT activity survey: 1990-2010. Bone Marrow Transplant 2012, 47:906-923.
2. Chevallier P., Robillard N., Illiaquer M., Esbelin J., Mohty M., Bodin-Bressollette C., et al. Characterization of various blood and graft sources: a prospective series. Transfusion 2013, 53:2020-2026.
3. Anderlini P., Korbling M. The use of mobilized peripheral blood stem cells from normal donors for allografting. Stem Cells 1997, 15:9-17.
4. McCredie K.B., Hersh E.M., Freireich E.J. Cells capable of colony formation in the peripheral blood of man. Science 1971, 171:293-294.
5. Utter G.H., Lee T.H., Rivers R.M., Montalvo L., Wen L., Chafets D.M., et al. Microchimerism decades after transfusion among combat-injured US veterans from the Vietnam, Korean, and World War II conflicts. Transfusion 2008, 48:1609-1615.
6. Hirayama F., Yamaguchi M., Yano M., Yasui K., Horie Y., Matsumoto K., et al. Spontaneous and rapid reexpression of functional CXCR4 by human steady-state peripheral blood CD34+ cells. Int J Hematol 2003, 78:48-55.
7. Brunet de la Grange P., Vlaski M., Duchez P., Chevaleyre J., Lapostolle V., Boiron J.M., et al. Long-term repopulating hematopoietic stem cells and "side population" in human steady state peripheral blood. Stem Cell Res 2013, 11:625-633.
8. Neron S., Thibault L., Dussault N., Cote G., Ducas E., Pineault N., et al. Characterization of mononuclear cells remaining in the leukoreduction system chambers of apheresis instruments after routine platelet collection: a new source of viable human blood cells. Transfusion 2007, 47:1042-1049.
9. Bensinger W.I. Allogeneic transplantation: peripheral blood vs. bone marrow. Curr Opin Oncol 2012, 24:191-196.
10. Peytour Y., Guitart A., Villacreces A., Chevaleyre J., Lacombe F., Ivanovic Z., et al. Obtaining of CD34+ cells from healthy blood donors: development of a rapid and efficient procedure using leukoreduction filters. Transfusion 2010, 50:2152-2157.
11. Dietz A.B., Bulur P.A., Emery R.L., Winters J.L., Epps D.E., Zubair A.C., et al. A novel source of viable peripheral blood mononuclear cells from leukoreduction system chambers. Transfusion 2006, 46:2083-2089.
12. Bertolini F., Battaglia M., Pedrazzoli P., Da Prada G.A., Lanza A., Soligo D., et al. Megakaryocytic progenitors can be generated ex vivo and safely administered to autologous peripheral blood progenitor cell transplant recipients. Blood 1997, 89:2679-2688.
13. Shpall E.J., Quinones R., Giller R., Zeng C., Baron A.E., Jones R.B., et al. Transplantation of ex vivo expanded cord blood. Biol Blood Marrow Transplant 2002, 8:368-376.
14. Jaroscak J., Goltry K., Smith A., Waters-Pick B., Martin P.L., Driscoll T.A., et al. Augmentation of umbilical cord blood (UCB) transplantation with ex vivo-expanded UCB cells: results of a phase 1 trial using the AastromReplicell System. Blood 2003, 101:5061-5067.
15. de Lima M., McMannis J., Gee A., Komanduri K., Couriel D., Andersson B.S., et al. Transplantation of ex vivo expanded cord blood cells using the copper chelator tetraethylenepentamine: a phase I/II clinical trial. Bone Marrow Transplant 2008, 41:771-778.
16. Pai M., Zacharoulis D., Milicevic M.N., Helmy S., Jiao L.R., Levicar N., et al. Autologous infusion of expanded mobilized adult bone marrow-derived CD34+ cells into patients with alcoholic liver cirrhosis. Am J Gastroenterol 2008, 103:1952-1958.
17. Duchez P., Chevaleyre J., Brunet de la Grange P., Vlaski M., Boiron J.M., Wouters G., et al. Cryopreservation of hematopoietic stem and progenitor cells amplified ex vivo from cord blood CD34+ cells. Transfusion 2013, 53:2012-2019.
18. Morrison S.J., Scadden D.T. The bone marrow niche for haematopoietic stem cells. Nature 2014, 505:327-334.
19. Anthony B.A., Link D.C. Regulation of hematopoietic stem cells by bone marrow stromal cells. Trends Immunol 2014, 35:32-37.
20. Mercier F.E., Ragu C., Scadden D.T. The bone marrow at the crossroads of blood and immunity. Nat Rev Immunol 2012, 12:49-60.
21. Hawkins K.E., Sharp T.V., McKay T.R. The role of hypoxia in stem cell potency and differentiation. Regen Med 2013, 8:771-782.
22. Guezguez B., Campbell C.J., Boyd A.L., Karanu F., Casado F.L., Di Cresce C., et al. Regional localization within the bone marrow influences the functional capacity of human HSCs. Cell Stem Cell 2013, 13:175-189.
23. Nombela-Arrieta C., Pivarnik G., Winkel B., Canty K.J., Harley B., Mahoney J.E., et al. Quantitative imaging of haematopoietic stem and progenitor cell localization and hypoxic status in the bone marrow microenvironment. Nat Cell Biol 2013, 15:533-543.
24. Ivanovic Z. Respect the anaerobic nature of stem cells to exploit their potential in regenerative medicine. Regen Med 2013, 8:677-680.
25. Gnaiger E. Oxygen conformance of cellular respiration. A perspective of mitochondrial physiology. Adv Exp Med Biol 2003, 543:39-55.
26. Jez M., Rozman P., Ivanovic Z., Bas T. Concise Review: The Role of Oxygen in Hematopoietic Stem Cells Physiology. J Cell Physiol 2015, 230:1999-2005.
27. Mohyeldin A., Garzon-Muvdi T., Quinones-Hinojosa A. Oxygen in stem cell biology: a critical component of the stem cell niche. Cell Stem Cell 2010, 7:150-161.
28. Eliasson P., Jonsson J.I. The hematopoietic stem cell niche: low in oxygen but a nice place to be. J Cell Physiol 2010, 222:17-22.
29. Eliasson P., Rehn M., Hammar P., Larsson P., Sirenko O., Flippin L.A., et al. Hypoxia mediates low cell-cycle activity and increases the proportion of long-term-reconstituting hematopoietic stem cells during in vitro culture. Exp Hematol 2010, 38:301-310 e2.
30. Guitart A.V., Hammoud M., Dello Sbarba P., Ivanovic Z., Praloran V. Slow-cycling/quiescence balance of hematopoietic stem cells is related to physiological gradient of oxygen. Exp Hematol 2010, 38:847-851.
31. Bendall S.C., Simonds E.F., Qiu P., Amir el A.D., Krutzik P.O., Finck R., et al. Single-cell mass cytometry of differential immune and drug responses across a human hematopoietic continuum. Science 2011, 332:687-696.
32. Qiu P., Simonds E.F., Bendall S.C., Gibbs K.D., Bruggner R.V., Linderman M.D., et al. Extracting a cellular hierarchy from high-dimensional cytometry data with SPADE. Nat Biotechnol 2011, 29:886-891.
33. Kidd B.A., Peters L.A., Schadt E.E., Dudley J.T. Unifying immunology with informatics and multiscale biology. Nat Immunol 2014, 15:118-127.
34. Keeney M., Chin-Yee I., Weir K., Popma J., Nayar R., Sutherland D.R. Single platform flow cytometric absolute CD34+ cell counts based on the ISHAGE guidelines. International Society of Hematotherapy and Graft Engineering. Cytometry 1998, 34:61-70.
35. Bordeaux-Rego P., Luzo A., Costa F.F., Olalla Saad S.T., Crosara-Alberto D.P. Both interleukin-3 and interleukin-6 are necessary for better ex vivo expansion of CD133+ cells from umbilical cord blood. Stem Cells Dev 2010, 19:413-422.
36. Seita J., Weissman I.L. Hematopoietic stem cell: self-renewal versus differentiation. Wiley Interdiscip Rev Syst Biol Med 2010, 2:640-653.
37. Kotecha N., Krutzik P.O., Irish J.M. Web-based analysis and publication of flow cytometry experiments. Curr Protoc Cytom 2010, Chapter 10: Unit10 7.
38. McKenzie J.L., Gan O.I., Doedens M., Dick J.E. Reversible cell surface expression of CD38 on CD34-positive human hematopoietic repopulating cells. Exp Hematol 2007, 35:1429-1436.
39. Manz M.G., Miyamoto T., Akashi K., Weissman I.L. Prospective isolation of human clonogenic common myeloid progenitors. Proc Natl Acad Sci U S A 2002, 99:11872-11877.
40. Doulatov S., Notta F., Eppert K., Nguyen L.T., Ohashi P.S., Dick J.E. Revised map of the human progenitor hierarchy shows the origin of macrophages and dendritic cells in early lymphoid development. Nat Immunol 2010, 11:585-593.
41. Chen L., Gao Z., Zhu J., Rodgers G.P. Identification of CD13+CD36+ cells as a common progenitor for erythroid and myeloid lineages in human bone marrow. Exp Hematol 2007, 35:1047-1055.
42. van Galen P., Kreso A., Mbong N., Kent D.G., Fitzmaurice T., Chambers J.E., et al. The unfolded protein response governs integrity of the haematopoietic stem-cell pool during stress. Nature 2014, 510:268-272.
43. Maecker H.T., McCoy J.P., Nussenblatt R. Standardizing immunophenotyping for the Human Immunology Project. Nat Rev Immunol 2012, 12:191-200.
44. Crocker P.R., Varki A. Siglecs, sialic acids and innate immunity. Trends Immunol 2001, 22:337-342.
45. Bonnet D. Hematopoietic stem cells. Birth Defects Res C Embryo Today 2003, 69:219-229.
46. Walter R.B., Appelbaum F.R., Estey E.H., Bernstein I.D. Acute myeloid leukemia stem cells and CD33-targeted immunotherapy. Blood 2012, 119:6198-6208.
47. Marsee D.K., Pinkus G.S., Yu H. CD71 (transferrin receptor): an effective marker for erythroid precursors in bone marrow biopsy specimens. Am J Clin Pathol 2010, 134:429-435.
48. Kiel M.J., Yilmaz O.H., Iwashita T., Terhorst C., Morrison S.J. SLAM family receptors distinguish hematopoietic stem and progenitor cells and reveal endothelial niches for stem cells. Cell 2005, 121:1109-1121.
49. Oguro H., Ding L., Morrison S.J. SLAM family markers resolve functionally distinct subpopulations of hematopoietic stem cells and multipotent progenitors. Cell Stem Cell 2013, 13:102-116.
50. Ivanovic Z., Duchez P., Morgan D.A., Hermitte F., Lafarge X., Chevaleyre J., et al. Whole-blood leuko-depletion filters as a source of CD 34+ progenitors potentially usable in cell therapy. Transfusion 2006, 46:118-125.
51. Peytour Y., Villacreces A., Chevaleyre J., Ivanovic Z., Praloran V. Discarded leukoreduction filters: a new source of stem cells for research, cell engineering and therapy?. Stem Cell Res 2013, 11:736-742.
52. Filippone C., Franssila R., Kumar A., Saikko L., Kovanen P.E., Soderlund-Venermo M., et al. Erythroid progenitor cells expanded from peripheral blood without mobilization or preselection: molecular characteristics and functional competence. PLoS One 2010, 5:e9496.
53. Olivier E., Qiu C., Bouhassira E.E. Novel, high-yield red blood cell production methods from CD34-positive cells derived from human embryonic stem, yolk sac, fetal liver, cord blood, and peripheral blood. Stem Cells Transl Med 2012, 1:604-614.
54. Hosing C., Saliba R.M., Hamerschlak N., Kutner J.M., Sakashita A.M., Kondo A.T., et al. Peripheral blood stem cell yield calculated using preapheresis absolute CD34+ cell count, peripheral blood volume processed, and donor body weight accurately predicts actual yield at multiple centers. Transfusion 2014, 54:1081-1087.
55. Gibbs K.D., Gilbert P.M., Sachs K., Zhao F., Blau H.M., Weissman I.L., et al. Single-cell phospho-specific flow cytometric analysis demonstrates biochemical and functional heterogeneity in human hematopoietic stem and progenitor compartments. Blood 2011, 117:4226-4233.
56. Beksac M., Preffer F. Is it time to revisit our current hematopoietic progenitor cell quantification methods in the clinic?. Bone Marrow Transplant 2012, 47:1391-1396.
57. Bender J.G., Unverzagt K.L., Walker D.E., Lee W., Van Epps D.E., Smith D.H., et al. Identification and comparison of CD34-positive cells and their subpopulations from normal peripheral blood and bone marrow using multicolor flow cytometry. Blood 1991, 77:2591-2596.
58. Herbein G., Sovalat H., Wunder E., Baerenzung M., Bachorz J., Lewandowski H., et al. Isolation and identification of two CD34+ cell subpopulations from normal human peripheral blood. Stem Cells 1994, 12:187-197.
59. Kato K., Radbruch A. Isolation and characterization of CD34+ hematopoietic stem cells from human peripheral blood by high-gradient magnetic cell sorting. Cytometry 1993, 14:384-392.
60. Zhang C.C., Sadek H.A. Hypoxia and metabolic properties of hematopoietic stem cells. Antioxid Redox Signal 2014, 20:1891-1901.
61. Tanner A., Taylor S.E., Decottignies W., Berges B.K. Humanized mice as a model to study human hematopoietic stem cell transplantation. Stem Cells Dev 2014, 23:76-82.
62. Duchez P., Chevaleyre J., de la Grange P.B., Vlaski M., Boiron J.M., Ivanovic Z. Functional stability (at +4 degrees c) of hematopoietic stem and progenitor cells amplified ex vivo from cord blood CD34+ cells. Cell Transplant 2013, 22:1501-1506.
63. Duchez P., Chevaleyre J., Vlaski M., Dazey B., Milpied N., Boiron J.M., et al. Definitive set-up of clinical-scale procedure for ex-vivo expansion of cord blood hematopoietic cells for transplantation. Cell Transplant 2012, 21:2517-2521.
64. Fares I., Chagraoui J., Gareau Y., Gingras S., Ruel R., Mayotte N., et al. Cord blood expansion. Pyrimidoindole derivatives are agonists of human hematopoietic stem cell self-renewal. Science 2014, 345:1509-1512.